Dr Neil Came
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
43 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Flow cytometric assessment of measurable residual disease in acute myeloid leukaemia: a summary of current Australasian practice and future directions
DOI: 10.1111/imj.703362026
Journal article
Detecting T-cell clones of uncertain significance using anti-TRBC1-based flow cytometry
DOI: 10.1016/j.pathol.2026.03.0062025
Journal article
Computational flow cytometry reveals a high prevalence of TRBC1-restricted CD8 T-cell subsets
DOI: 10.1080/10428194.2025.24846432024
Journal article
Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications
DOI: 10.1111/bjh.194272024
Journal article
Issue highlights—April 2024
DOI: 10.1002/cyto.b.221712024
Journal article
Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing
DOI: 10.1111/bjh.192522020
Journal article
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months
DOI: 10.1182/bloodadvances.2019000864
RECENT SCHOLARLY WORKS
2024
Journal article
T-cell clones of uncertain significance in the era of increasingly sensitive flow-cytometry detection
DOI: 10.1016/j.pathol.2023.12.0902023
Journal article
Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia
DOI: 10.1111/bjh.188022022
Journal article
Computational Flow Cytometry Provides Accurate and Sensitive Measurable Residual Disease Assessment in Chronic Lymphocytic Leukemia
DOI: 10.1182/blood-2022-1656492022
Journal article
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis
DOI: 10.1002/cyto.b.22053